Osamura RY, Grossman A, Korbonits M, Kovacs K, Lopes MBS, Matsuno A, et al (2017) Tumors of the pituitary gland. In: Lloyd RV, Osamura RY, Klöppel G, Rosai J (eds). WHO Classification of Tumours of Endocrine Organs; 4th ed. WHO International Agency for Research and Cancer (IARC), Lyon, pp 14–18
Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24:C5–C8
CAS PubMed Article Google Scholar
Villa C, Vasiljevic A, Jaffrain-Rea ML, Ansorge O, Asioli S, Barresi V, Chinezu L, Gardiman MP, Lania A, Lapshina AM, Poliani L et al (2019) A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch 475:687–692
CAS PubMed Article Google Scholar
Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, Krijger RR, Dietel M, El-Naggar AK et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) Expert Consensus proposal. Mod Pathol 31:1770–1786
PubMed PubMed Central Article Google Scholar
Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C et al (2019) A tale of pituitary adenomas: to NET or not to NET. Pituitary 22:569–573
Klimstra DS, Klöppel G, La Rosa S, Rindi G (2019) Classification of neuroendocrine neoplasms of the digestive system. In: Arends MJ, Fukuyama M, Klimstra DS, Lam, AKY, Nagtegaal ID, Odze RD. WHO Classification of Tumours: Digestive system Tumors, 5th ed. WHO International Agency for Research and Cancer (IARC), Lyon, pp.17–22.
Asa SL (2021) Challenges in the diagnosis of pituitary neuroendocrine tumors. Endocr Pathol 32:222–227
Lloyd RV, Osamura RY, Klöppel G et al (2017) World Health Organization classification of tumours of endocrine organs, 4th edn. IARC Publication, Lyon
Chen Y, Wang CD, Su ZP, Chen YX, Cai L, Zhuge QC, Wu ZB (2012) Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Neuroendocrinology 96:333–342
CAS PubMed Article Google Scholar
Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M, Reimondo G, Del Monte P, Bernasconi D, Loli P, Faustini-Fustini M et al (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol 155:823–829
CAS PubMed Article Google Scholar
Mete O, Gomez-Hernandez K, Kucharczyk W, Ridout R, Zadeh G, Gentili F, Ezzat S, Asa SL (2016) Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol 29:131–142
CAS PubMed Article Google Scholar
Karavitaki N, Collison K, Halliday J, Byrne JV, Price P, Cudlip S, Wass JA (2007) What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol 67:938–943
Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21:111–118
Araujo-Castro M, Berrocal VR, Pascual-Corrales E (2020) Pituitary tumors: epidemiology and clinical presentation spectrum. Hormones (Athens) 19:145–155
Drummond JB, Ribeiro-Oliveira A Jr, Soares BS, Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K et al (2018) Non-functioning pituitary adenomas. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (eds) Endotext. MDText.com Inc, South Dartmouth, p 2000
Asa SL, Ezzat S (2016) Aggressive pituitary tumors or localized pituitary carcinomas: defining pituitary tumors. Expert Rev Endocrinol Metab 11:149–162
CAS PubMed Article Google Scholar
Ceccato F, Regazzo D, Barbot M, Denaro L, Emanuelli E, Borsetto D, Rolma G, Alessio L, Gardiman MP, Lombardi G et al (2018) Early recognition of aggressive pituitary adenomas: a single-centre experience. Acta Neurochir 160:49–55
Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G (2015) Aggressive pituitary tumors. Neuroendocrinology 101:87–104
CAS PubMed Article Google Scholar
Colao A, Grasso LFS, Pivonello R, Lombardi G (2011) Therapy of aggressive pituitary tumors. Expert Opin Pharmacother 12:1561–1570
CAS PubMed Article Google Scholar
Di Ieva A, Rotondo F, Syro LV, Cusimano MD, Kovacs K (2014) Aggressive pituitary adenomas—diagnosis and emerging treatments. Nat Rev Endocrinol 10:423–435
PubMed Article CAS Google Scholar
Dworakowska D, Grossman AB (2018) Aggressive and malignant pituitary tumours: state-of-the-art. Endocr-Relat Cancer 25:R559–R575
CAS PubMed Article Google Scholar
Mete O, Ezzat S, Asa SL (2012) Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49:R69–R78
CAS PubMed Article Google Scholar
Priola SM, Esposito F, Cannavò S, Conti A, Abbritti RV, Barresi V, Baldari S, Ferraù F, Germanò A, Tomasello F et al (2017) Aggressive pituitary adenomas: the dark side of the moon. World Neurosurg 97:140–155
Sav A, Rotondo F, Syro LV, Di Ieva A, Cusimano MD, Kovacs K (2015) Invasive, atypical and aggressive pituitary adenomas and carcinomas. Endocrinol Metab Clin N Am 44:99–104
Syro LV, Rotondo F, Ortiz LD, Kovacs K (2018) 65 YEARS OF THE DOUBLE HELIX: treatment of pituitary tumors with temozolomide: an update. Endocr-Relat Cancer 25:T159–T169
CAS PubMed Article Google Scholar
Zheng X, Li S, Zhang W, Zang Z, Hu J, Yang H (2016) Current biomarkers of invasive sporadic pituitary adenomas. Ann Endocrinol 77:658–667
Hardy J (1969) Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16:185–217
CAS PubMed Article Google Scholar
Wilson CB (1979) Neurosurgical management of large and invasive pituitary tumors. In: Tindall GT, Collins W (eds) Clinical management of pituitary disorders. Raven Press, New York, pp 335–342
Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space. Neurosurgery 33:610–618
Micko ASG, Wöhrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122:803–811
Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123–135
Trouillas J, Burman P, McCormack A, Petersenn S, Popovic V, Dekkers O, Raverot G (2018) Aggressive pituitary tumours and carcinomas: two sides of the same coin? Eur J Endocrinol 178:C7–C9
CAS PubMed Article Google Scholar
Lelotte J, Mourin A, Fomekong E, Michotte A, Raftopoulos C, Maiter (2018) Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients. Eur J Endocrinol 178:237–246
CAS PubMed Article Google Scholar
Petersenn S (2019) Management of aggressive pituitary tumors—a 2019 update. Horm Metab Res 51:755–764
CAS PubMed Article Google Scholar
Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM, European Society of Endocrinology (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178:G1–G24
CAS PubMed Article Google Scholar
Ravenot G, Ilie MD, Lasolle H, Amodru V, Trouillas J, Castinetti F, Brue T (2021) Aggressive pituitary tumours and pituitary carcinomas. Nat Rev Endocrinol 17:671–684
Miermeister CP, Petersenn S, Buchfelder M, Fahlbusch R, Lüdecke DK, Hölsken A, Bergmann M, Knappe HU, Hans VH, Flitsch J et al (2015) Histological criteria for atypical pituitary adenomas—data from the German pituitary adenoma registry suggests modifications. Acta Neuropathol Commun 3:50
PubMed PubMed Central Article CAS Google Scholar
Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F, Jouanneau E, Roy P, Trouillas J (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102:3368–3374
Asioli S, Righi A, Iommi M, Baldovini C, Ambrosi F, Guaraldi F, Zoli M, Mazzatenta D, Faustini-Fustini M, Rucci P et al (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol 180:127–134
CAS PubMed Article Google Scholar
Tampourlou M, Fountas A, Ntali G, Karavitaki N (2018) Mortality in patients with non-functioning pituitary adenoma. Pituitary 21:203–207
PubMed PubMed Central Article Google Scholar
Greenman Y, Stern N (2015) Optimal management of non-functioning pituitary adenomas. Endocrine 50:51–55
CAS PubMed Article Google Scholar
Olsson DS, Hammarstrand C, Bryngelsson I-L, Nilsson AG, Andersson E, Johannsson G, Ragnarsson O (2017) Incidence of malignant tumours in patients with a non-functioning pituitary adenoma. Endocr-Relat Cancer 24:227–235
留言 (0)